Drug Profile
Z 203
Alternative Names: 0632; T 0632Latest Information Update: 31 Oct 2005
Price :
$50
*
At a glance
- Originator Tanabe Seiyaku
- Developer Tanabe Seiyaku; Zeria
- Class
- Mechanism of Action Cholecystokinin A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pancreatitis